Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Acasti Pharma Inc.

TRADE

NASDAQ: ACSTHealthcare / Biotechnology / Canada
0.49+0.01+2.08%Vol 66 4861Y Perf -63.62%
Aug 21st, 2018 15:57
BID0.48 ASK0.49
Open0.48 Previous Close0.48
Pre-Market- After-Trading-
 - -%  - -%
Target Price
3.63 
Analyst Rating
Strong Buy 1.43
Potencial %
640.82 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
     33.67
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Price Range Ratio 52wk %
2.05 
Earnings Date

Today's Price Range

0.450.50

 

52wk Range

0.433.36

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
-14.29%
3 Months
-36.00%
6 Months
-51.52%
1 Year
-63.62%
3 Years
-87.03%
5 Years
-98.32%

Quotes

Name / TickerPriceChg.Chg.%
ACST0.490.01002.08
AAPL215.04-0.4200-0.19
GOOG1 201.62-6.1500-0.51
MSFT105.98-0.8900-0.83
XOM78.830.02000.03
WFC58.96-0.0700-0.12
JNJ135.35-1.5300-1.12
FB172.620.12000.07
GE12.630.33002.68
JPM115.320.70000.61
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.30
Current Ratio 1.40
Long Term Debt to Total Capital 0.18
Total Debt to Equity 0.22
Interest Coverage -162.40
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-162.30
EBIT Margin-34 664.40
EBITDA Margin-25 968.80
Pre-tax Profit Margin-7 486.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.96
PS Ratios 22 959.00
Price to Cash Flow -
Price to Free Cash Flow -1.30
Cash Flow Per Share -0.76
Price to Tangible Book2.96
Book Value per Share0.16
Enterprise Value (in ths.)8 184
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-43.02
ROE last 12 Months -197.21
Return on Assets (5Y Avg) -42.34
ROA last 12 Months -105.77
Return on Capital (5Y Avg) -31.80
ROC last 12 Months -175.99
Return on invested Capital Q -77.39
Return on invested Capital Y-130.01
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -77.66
Revenue Growth 5 Years -64.51
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.31-0.310.00
Q01 2017--0.23-
Q04 2016--0.13-
Q03 2016--0.16-
Q02 2016--0.01-
Q01 2016--0.01-
Q04 2015--0.02-
Q03 2015-0.030.03200.00
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.200.00-
3/2018 QR-0.20--
----
----
Next Report Date10th Oct 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume66 486
Shares Outstanding (in ths.)36 630
Trades Count39
Dollar Volume31 442
Avg. Volume274 279
Avg. Weekly Volume89 057
Avg. Monthly Volume228 579
Avg. Quarterly Volume243 922

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

64%36%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.43
Strong Buy
1.43
Strong Buy
1.00

There are no comments yet.

News

x